To include your compound in the COVID-19 Resource Center, submit it here.

NCI starts trial of targeted cancer treatments

NIH's National Cancer Institute launched the single-blind Phase II M-PACT trial to evaluate whether treatment based on specific gene mutations improves the rate

Read the full 237 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE